RxSight (RXST) Revenue Growth (1y) (2021 - 2026)
RxSight (RXST) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | 6.08% |
| 10 | RxSight | 228.01 Mn | -190.20 Mn | 23.50 Mn | -18.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.48% |
| Dec 31, 2025 | -18.91% |
| Sep 30, 2025 | -14.09% |
| Jun 30, 2025 | -3.58% |
| Mar 31, 2025 | 28.41% |
| Dec 31, 2024 | 40.71% |
| Sep 30, 2024 | 59.08% |
| Jun 30, 2024 | 67.65% |
| Mar 31, 2024 | 68.75% |
| Dec 31, 2023 | 77.65% |
| Sep 30, 2023 | 75.97% |
| Jun 30, 2023 | 83.19% |
| Mar 31, 2023 | 95.58% |
| Dec 31, 2022 | 90.93% |
| Sep 30, 2022 | 118.03% |
| Jun 30, 2022 | 131.98% |
| Mar 31, 2022 | 156.66% |
| Dec 31, 2021 | 189.46% |
| Sep 30, 2021 | 38.75% |
| Jun 30, 2021 | 80.97% |